MDMA and Psilocybin are supplied to authorized clinics in regulated markets.
Optimi Health supplies two psychedelic drug products—MDMA and Psilocybin—exclusively through regulated clinical and medical access programs.
Products are supplied for supervised clinical environments, with direct-to-clinic distribution supporting traceability and regulatory compliance.
